help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Larramendy, M. L.
Right arrow Articles by Knuutila, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Larramendy, M. L.
Right arrow Articles by Knuutila, S.

American Journal of Pathology, Vol 150, 685-691, Copyright © 1997 by American Society for Investigative Pathology


REGULAR ARTICLES

Gains, losses, and amplifications of DNA sequences evaluated by comparative genomic hybridization in chondrosarcomas

ML Larramendy, M Tarkkanen, J Valle, AH Kivioja, H Ervasti, E Karaharju, T Salmivalli, I Elomaa and S Knuutila
Department of Medical Genetics, Haartman Institute, University of Helsinki, Finland.

Comparative genomic hybridization was used to search for previously unknown gains and losses of DNA sequences along all chromosome arms in 29 chondrosarcoma specimens obtained from 23 patients. Extensive genetic aberrations, with a mean of 6 changes per tumor (range, 1 to 24), were detected in 21 of the 29 samples analyzed (72%). The majority of these changes were gains of whole chromosomes or whole chromosome arms. Gains of DNA sequence copy number were most frequent at 20q (38%), 17p (38%), 20p (31%), 1cen-q24 (28%), and 14q23-qter (28%). High- level amplifications of small chromosome regions were sporadic, detected in only 17% of the samples. The only recurrent high-level amplification, seen in two tumors (7%), affected the minimal common region 12cen-q15. Other amplifications, each encountered only once, involved 1p33-p35, 2p23-pter, 4p, 6p22-pter, 18q12-q22, 19p13.2, 19q13.2, and 20q13.1. Losses of DNA sequences were rare and were most commonly observed at 6cen-q22 (17%) and 9p (17%).


This article has been cited by other articles:


Home page
The OncologistHome page
H. Gelderblom, P. C.W. Hogendoorn, S. D. Dijkstra, C. S. van Rijswijk, A. D. Krol, A. H.M. Taminiau, and J. V.M.G. Bovee
The Clinical Approach Towards Chondrosarcoma
Oncologist, March 1, 2008; 13(3): 320 - 329.
[Abstract] [Full Text] [PDF]


Home page
INT J SURG PATHOLHome page
C. Gebert, C. Brinkschmidt, S. Bielack, T. Bernhardt, H. Jurgens, W. Bocker, W. Winkelmann, H. Burger, and G. Gosheger
The potential of comparative genomic hybridization as a tool in the differential diagnosis of matrix-producing bone lesions.
International Journal of Surgical Pathology, July 1, 2006; 14(3): 187 - 192.
[Abstract] [PDF]


Home page
JCOHome page
C. Morrison, M. Radmacher, N. Mohammed, D. Suster, H. Auer, S. Jones, J. Riggenbach, N. Kelbick, G. Bos, and J. Mayerson
MYC Amplification and Polysomy 8 in Chondrosarcoma: Array Comparative Genomic Hybridization, Fluorescent In Situ Hybridization, and Association With Outcome
J. Clin. Oncol., December 20, 2005; 23(36): 9369 - 9376.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. J. Reichenberger, R. D. Coletta, A. P. Schulte, M. Varella-Garcia, and H. L. Ford
Gene Amplification Is a Mechanism of Six1 Overexpression in Breast Cancer
Cancer Res., April 1, 2005; 65(7): 2668 - 2675.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. J. Evans, B. L. Gallie, M. A.S. Jewett, G. R. Pond, K. Vandezande, J. Underwood, Y. Fradet, G. Lim, P. Marrano, M. Zielenska, et al.
Defining a 0.5-Mb Region of Genomic Gain on Chromosome 6p22 in Bladder Cancer by Quantitative-Multiplex Polymerase Chain Reaction
Am. J. Pathol., January 1, 2004; 164(1): 285 - 293.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. G. Callow, F. Clairvoyant, S. Zhu, B. Schryver, D. B. Whyte, J. R. Bischoff, B. Jallal, and T. Smeal
Requirement for PAK4 in the Anchorage-independent Growth of Human Cancer Cell Lines
J. Biol. Chem., January 4, 2002; 277(1): 550 - 558.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
J. W. Gray and C. Collins
Genome changes and gene expression in human solid tumors
Carcinogenesis, March 1, 2000; 21(3): 443 - 452.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. A. Heiskanen, M. L. Bittner, Y. Chen, J. Khan, K. E. Adler, J. M. Trent, and P. S. Meltzer
Detection of Gene Amplification by Genomic Hybridization to cDNA Microarrays
Cancer Res., February 1, 2000; 60(4): 799 - 802.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
W.'e. El-Rifai, M. Sarlomo-Rikala, S. Knuutila, and M. Miettinen
DNA Copy Number Changes in Development and Progression in Leiomyosarcomas of Soft Tissues
Am. J. Pathol., September 1, 1998; 153(3): 985 - 990.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Society for Investigative Pathology.